Company Overview
Hanmi Science
A global leading healthcare company devoted to a healthy life for humanity
Hanmi Science is the operating holding company of Hanmi Group, presenting integrated strategies and visions that maximize synergy among key group companies and subsidiaries, including Hanmi Pharm, Online Pharm, and JVM. Beyond its holding business, it is expanding its business scope by simultaneously targeting general consumers and corporate clients through various independent ventures such as food, cosmetics, medical devices, and IT solutions. Furthermore, by distributing Hanmi Pharm's specialized pharmaceuticals and Hanmi Science's healthcare products, it creates value across the entire healthcare ecosystem and serves as the group's central hub based on strategic links among group companies and its own business capabilities. Based on the management philosophies of 'Respect for Humanity' and 'Value Creation', it is striving to drive the group's sustainable innovation and growth and to leap forward as a first mover in the Korean healthcare industry.
Company Name | Hanmi Science |
|---|---|
CEO | Kim Jae-gyo |
Date of Establishment | June 15, 1973 |
Date of Spin-off | July 1, 2010, the launch of Hanmi Holdings (currently Hanmi Science) as a holding company. |
Business Site Address | Head Office: 14 Wiryeseong-daero, Songpa-gu, Seoul |
Key Businesses | Primary Business Objectives: Holding company business, healthcare business, pharmaceutical wholesale |
Status of Major Shareholders and Subsidiaries (Including Affiliates)
Open Square for Tomorrow, Hanmi C&C Square
In November 2025, Hanmi C&C Square, a new office and welfare complex for Hanmi Group, was completed. It spans five basement floors and thirteen above-ground floors, with a total floor area of 7,305.9㎡. The 'C&C' in Hanmi C&C Square stands for Creation and Challenge, Connect and Communicate, which are Hanmi Group's top priorities.
Beyond a simple workspace, Hanmi C&C Square will be utilized as a complex space that encompasses employees' family, health, and cultural needs. Currently, in addition to office spaces, it operates an in-house daycare center, an employee fitness center, and an exclusive employee café (Equal Garden).
Hanmi Group will foster a work culture where employees can simultaneously enhance work efficiency and quality of life in the optimal environment, thereby driving sustainable innovation.
Key Certifications Status
Certification | Content | Period |
ISO 45001 | Occupational Health and Safety Management System | 2024.10.29 ~ 2027.10.28 |
ISO 9001 | Quality Management System | 2024.08.26 ~ 2027.08.25 |
Production Facility | Songtan Plant
Hanmi Science's Songtan Plant, located in Pyeongtaek-si, Gyeonggi-do, produces Whole Soy Milk and other beverages, as well as OEM/ODM products. It has a total of four paper-pack production lines from SIG, a global aseptic paper-pack brand, capable of producing up to 321.41 million packs of beverages annually. Equipped with state-of-the-art facilities for peeling, roasting, blending, and sterilization, it swiftly carries out all necessary processes for beverage manufacturing, from raw material pretreatment to blending and mass production.
Key Certifications Status
Certification Name | Content | Period |
ISO 45001 | Occupational Health and Safety Management System | 2024.10.29 ~ 2027.10.28 |
HACCP Processed Soy Milk | Food Safety Management Certification Standard - Processed Soy Milk | 2024.05.15 ~ 2027.05.14 |
HACCP Fruit and Vegetable Drinks | Food Safety Management Certification Standard - Fruit and Vegetable Drinks | 2024.05.15 ~ 2027.05.14 |
HACCP Fruit and Vegetable Juices | Food Safety Management Certification Standard - Fruit and Vegetable Juices | 2024.05.15 ~ 2027.05.14 |
HACCP Nutritional Prepared Foods for Diabetics | Food Safety Management Certification Standard - Nutritional Prepared Foods for Diabetics | 2024.05.15 ~ 2027.05.14 |
HACCP Concentrated Soy Milk | Food Safety Management Certification Standard - Concentrated Soy Milk | 2024.05.15 ~ 2027.05.14 |
HACCP Balanced Nutritional Prepared Foods for General Patients | Food Safety Management Certification Standard - Balanced Nutritional Prepared Foods for General Patients | 2024.05.15 ~ 2027.05.14 |
HACCP Mixed Drinks | Food Safety Management Certification Standard - Mixed Drinks | 2024.05.15 ~ 2027.05.14 |
KVC | Vegan Certification Standard | 2022.10.04 ~ 2026.05.19 |
Logistics Center | Pyeongtaek Logistics Center
Located in Pyeongtaek-si, Gyeonggi-do, the Pyeongtaek Logistics Center of Hanmi Science is a key logistics hub, newly built in 2021 with a total floor area of 24,224 m² (7,328 pyeong), warehousing, inbound, and outbound operations for soy milk and healthcare products. By establishing a real-time logistics management system based on SAP and WMS (Warehouse Management System) integration, it processes approximately 214 million soy milk packs annually produced at the Songtan factory and systematically manages the inventory of various healthcare products, including cosmetics and health functional foods. Through logistics concentration and system-based operations, it minimizes unnecessary transportation and resource waste, contributing to the reduction of indirect carbon emissions, and strengthens internal control and responsible management through safe supply chain management and transparent logistics history management of food and healthcare products.
Logistics Center | Songpa Logistics Center
Located in Songpa-gu, Seoul, Hanmi Science 's Songpa Logistics Center leverages years of healthcare distribution know-how to provide customers with the best service, going beyond mere inbound/outbound and storage to include quality management and customer-centric services based on GSP (Good Supply Practices for Medical Devices). It handles 100 medical devices, human tissues, diagnostic reagents, etc., including Guardix, Acticlot, and MONOFIX, processing 1.2 million units of cargo annually.
Key Subsidiary | Online Pharm
Online Pharm is a specialized healthcare distribution company. Leading with the synergy between its professional pharmaceutical distribution platform 'HMP Mall' and a strong offline pharmacy sales network, it comprehensively provides products and services necessary for pharmacy and hospital management. It operates IT-based solutions such as 'On-Kiosk' for pharmacies and 'On-Connect' for smart pharmaceutical transaction management, and distributes OTC products and cosmetics from various pharmaceutical companies, including Hanmi Pharmaceutical, as well as JVM's automated drug dispensing solutions.
Company Name | Online Pharm |
CEO | Woo Ki Seok |
Date of Establishment | April 1, 2012 |
Business Site Address | Headquarters: Hanmi C&C Square, 5 Wiryeseong-daero 2-gil, Songpa-gu, Seoul |
Key Businesses | Main Business Purpose: Pharmaceutical Wholesale/Retail |
Shareholder Composition Status | Hanmi Science (100%) |
Online Pharm Board of Directors
Online Pharm's Board of Directors is composed of professional executives with rich experience and expert knowledge in various fields, handling the company's critical decision-making matters, proactively preventing various potential risks, and conducting self-assessments of the management's performance.
Composition | 1 Executive Director, 2 Non-Executive Directors, 1 Auditor |
Director Diversity | 3 Male / 1 Female |
Director Term | 3 years |
Prevention of Conflicts of Interest | Online Pharm adheres to the rules concerning Board of Directors ethics under the same conditions as Hanmi Science 's Board of Directors Regulations. Therefore, directors are required to notify the Board of all situations where conflicts of interest may arise and to submit them for deliberation. Currently, the Board has not identified any conflicts of interest. |
Regarding Key Sustainability | Online Pharm strives to overcome potential risks and create economic, social, and environmental value through communication with stakeholders in the pharmaceutical distribution process. The company monitors various risks arising in the relevant industry and conducts periodic reviews and preventive activities to address key risks. To ensure a rapid response to risk occurrences, the entire company is making efforts to check and improve crisis response capabilities by conducting simulations for each major risk. |
Board Performance Evaluation | Compensation for the Online Pharm Board of Directors is calculated based on the same short-term incentive operating standards as Hanmi Science, and after the final amount is determined through CEO adjustment, it is paid within the scope approved by the general meeting of shareholders. |
Key Certifications Status
Certification Name | Content | Period |
|---|---|---|
ISO 14001 | Environmental Management System | 2023.10.26 ~ 2026.10.27 |
ISO 9001 | Quality Management System | 2023.10.26 ~ 2026.10.27 |
ISMS | Information Security Management System | 2023.05.03 ~ 2026.05.02 |
Key Group Company | Hanmi Pharmaceutical
Hanmi Pharmaceutical, established in 1973, is a leading R&D-focused pharmaceutical and biotech company in Korea. It has demonstrated its R&D capabilities through accelerating clinical development of innovative new drug pipelines, securing First-in-Class drugs, and initiating numerous next-generation oncology projects based on novel modalities. Furthermore, with clinical progress in key obesity/metabolic disease treatments and a track record of academic achievements, the company is moving towards innovation based on continuous R&D and a challenging spirit. By 2030, the company aims to expand beyond oncology, obesity, and metabolic disease research to include anti-aging and rejuvenation research, making it a new period of leap.
Company Name | Hanmi Pharmaceutical |
|---|---|
CEO | Hwang Sangyoun |
Date of Establishment | June 15, 1973 (Date of spin-off: July 1, 2010) |
Business Site Address | Head Office : 14 Wiryeseong-daero, Songpa-gu, Seoul |
Key Businesses | Business Objectives : Pharmaceutical manufacturing and sales, global innovative new drug development |
Key Infrastructure
Paltan Smart Plant
Pyeongtaek Bioplant
Key Subsidiaries
Beijing Hanmi Pharmaceutical
Hanmi Fine Chemical
Key Group Company | JVM
Established in 1977 and integrated into Hanmi Group in 2016, JVM is a specialized company in pharmaceutical automation systems. It supports the innovation of work environments in hospitals and pharmacies worldwide through cutting-edge drug dispensing and management automation solutions. JVM has accumulated hardware and software technologies capabilities for pharmaceutical management automation for over 40 years. It has established itself as a leading company in pharmaceutical management automation systems, pioneering global pouch-type automated dispensing solutions and pharmacy automation.
Company Name | JVM |
CEO | Kim Sang Wook |
Date of Establishment | June 20, 1977 (Integrated into Hanmi Science in July 2016) |
Business Site Address | Headquarters (Factory 1): 121 Hosandong-ro, Dalseo-gu, Daegu |
Key Businesses | Primary Business: Development and sales of hospital/pharmacy automation solutions |
Key Infrastructure
